📊 GEX Options Sentiment – Bullish Setup
The GEX (Gamma Exposure) landscape for NVDA shows strong bullish pressure:
* Highest Positive GEX & Gamma Wall at $147.80, which NVDA is testing now.
* Call Walls stacked at:
* $148.00 (59% GEX7)
* $149.00 (76.85% GEX8)
* $150.00 (76.23% GEX9)
* IVR: 1.7 (low implied volatility)
* Calls $%: 5.8%
* Sentiment: 🟢🟢🟢 (bullish)
This zone between 147.80–150 is a high-confluence area for a gamma squeeze, especially if NVDA can push and close above 148.00.
✅ Options Suggestion:
Consider 146C–150C (6/28 or 7/5 expiry) if NVDA reclaims 147.80 cleanly with volume. Low IVR makes this attractive for directional plays.
📉 1H Trading Plan – Price Action Analysis
On the 1H chart:
* Structure: Clean Break of Structure (BOS) after reclaiming previous resistance near 145.
* Current price is consolidating in a small supply zone (purple box) at highs.
* Trendline support from June lows is intact.
* Previous CHoCH levels and demand zone between 142–143 remain unbroken — a bullish structure.
Trade Scenarios:
🔼 Bullish Breakout Setup:
* Entry: Above 148.00 breakout (watch for volume confirmation)
* Target: 149.50 → 152.00 → 154.00 (top GEX zones)
* Stop: Below 145.00 (invalidates the breakout)
🔽 Bearish Fade (Only if rejection):
* Entry: Rejection from 148.00 with high volume + failed reclaim
* Target: 145.00 → 143.50
* Stop: Above 148.50
🎯 Final Thoughts
NVDA is sitting right under its gamma squeeze trigger. A breakout above 148 backed by GEX momentum could see a quick move toward 150+. This is a high-conviction zone — but don’t chase blindly. Watch price action around 147.80–148.00 for confirmation.
This analysis is for educational purposes only and not financial advice. Trade at your own risk and always use proper risk management.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.